Phio Pharmaceuticals Corp.

11/19/2024 | Press release | Distributed by Public on 11/19/2024 06:51

Phio Pharmaceuticals Announces Completion of Enrollment in Second Cohort in Phase 1b Dose-Escalating Clinical Study